Labor Day hours

Labor Day, Monday, September 1: ARC Far West, ARC Round Rock, and ARC Southwest After Hours Clinics will be open 8am - 5pm on Labor Day, Monday, September 1. All other ARC clinics will be closed in observance of Labor Day.

Measles - Local update

Local health departments have not recommended additional vaccination beyond current guidelines. Texas health officials urge immunization to protect against and prevent the spread of measles. ARC has received additional vaccines for children and adults to keep the community protected. Read our measles vaccination guidelines.

Visit the DSHS website to track the current outbreak in Texas.

ARC MyChart Update

ARC MyChart Update: Due to updates to ARC MyChart, it will be unavailable Saturday, September 6, 7:00pm – Sunday, September 7, 7:00am. You will receive an email about the updates. Call 512-272-4636 to schedule a visit or speak with a nurse.

MyChart Login Help Me Book

Enrolling Studies

The research team at ARC is currently managing several different clinical studies. Are you interested in a particular study opportunity? Information about current study opportunities currently enrolling patients can be found below. Both ARC patients and non-ARC patients who fit the trial eligibility requirements are welcome.

  • BaxDuo Arctic Chronic Kidney Disease (CKD) Clinical Study

    A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

    About the Study

  • BaxDuo Pacific Chronic Kidney Disease (CKD) Clinical Study

    A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression and cardiovascular events in participants with CKD and high blood pressure.

    About the Study

  • ENABLE Multiple Sclerosis (MS) Clinical Study

    A long-term observational registry study for patients with multiple sclerosis (MS) to collect real-world data on BRIUMVI (infusion medication) and assess efficacy, safety, and tolerability of medication.

    About the Study